Post hoc analysis of 960 patients with AF at least 12 months after drug-eluting stenting: NOAC monotherapy vs NOAC plus clopidogrel was associated with fewer net adverse clinical events after complex PCI (9.5% vs 21.5%; HR 0.42) and noncomplex PCI (9.6% vs 15.7%; HR 0.59).
Secondary analysisn = 960
Jeon et al. Antithrombotic Therapy in Patients With Atrial Fibrillation With Prior Complex PCI: A Secondary Analysis of the Randomized ADAPT AF-DES Trial